Literature DB >> 10163457

Macular disease and optical coherence tomography.

J G Coker1, J S Duker.   

Abstract

Optical coherence tomography (OCT) is a new diagnostic tool for high-resolution cross-sectional imaging of the retina. By measuring the "echo" delay time of light as it reflects from tissue at different ranges and by performing multiple axial scans in the transverse direction, OCT generates two-dimensional images detailing retinal architecture. OCT is a powerful new modality because it has a longitudinal resolution of 10 microns in the retina, which is superior to other currently available imaging techniques. Examinations are exceptionally tolerable for patients because OCT is noninvasive, the probe beam is near-infrared and thus not very bright, and scan acquisition time is only 2.5 seconds. OCT appears to be a useful device for evaluating a variety of retinal diseases, including macular holes, macular edema, and central serous chorioretinopathy.

Entities:  

Mesh:

Year:  1996        PMID: 10163457     DOI: 10.1097/00055735-199606000-00006

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  14 in total

1.  Restoration of the photoreceptor outer segment and visual outcomes after macular hole closure: spectral-domain optical coherence tomography analysis.

Authors:  Masataka Shimozono; Akio Oishi; Masayuki Hata; Yasuo Kurimoto
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-04-17       Impact factor: 3.117

2.  [Time domain OCT versus frequency domain OCT: measuring differences of macular thickness in healthy subjects].

Authors:  S Chaber; H Helbig; Ma Gamulescu
Journal:  Ophthalmologe       Date:  2010-01       Impact factor: 1.059

3.  Recovery of photoreceptor outer segments after anti-VEGF therapy for age-related macular degeneration.

Authors:  Akio Oishi; Masataka Shimozono; Michiko Mandai; Masayuki Hata; Akihiro Nishida; Yasuo Kurimoto
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-05-12       Impact factor: 3.117

4.  From Imaging the Brain to Imaging the Retina: Optical Coherence Tomography (OCT) in Schizophrenia.

Authors:  Carlos Schönfeldt-Lecuona; Thomas Kregel; Arno Schmidt; Elmar H Pinkhardt; Florian Lauda; Jan Kassubek; Bernhard J Connemann; Roland W Freudenmann; Maximilian Gahr
Journal:  Schizophr Bull       Date:  2015-06-05       Impact factor: 9.306

5.  Exploring the role of macular thickness as a potential early biomarker of neurodegeneration in acute schizophrenia.

Authors:  Sukanto Sarkar; A R Rajalakshmi; S Avudaiappan; S Eswaran
Journal:  Int Ophthalmol       Date:  2021-04-15       Impact factor: 2.031

6.  Analysis of normal peripapillary choroidal thickness via spectral domain optical coherence tomography.

Authors:  Joseph Ho; Lauren Branchini; Caio Regatieri; Chandrasekharan Krishnan; James G Fujimoto; Jay S Duker
Journal:  Ophthalmology       Date:  2011-06-23       Impact factor: 12.079

7.  High resolution imaging of epithelial injury in the sheep cervicovaginal tract: a promising model for testing safety of candidate microbicides.

Authors:  Kathleen L Vincent; Nigel Bourne; Brent A Bell; Gracie Vargas; Alai Tan; Daniel Cowan; Lawrence R Stanberry; Susan L Rosenthal; Massoud Motamedi
Journal:  Sex Transm Dis       Date:  2009-05       Impact factor: 2.830

Review 8.  Perspectives on diagnosis and management of adult idiopathic intracranial hypertension.

Authors:  Irini Chatziralli; Panagiotis Theodossiadis; George Theodossiadis; Ioannis Asproudis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-04-04       Impact factor: 3.117

9.  Diagnostic accuracy of the Retinal Thickness Analyser: differentiation between normal eyes and eyes with glaucoma or macular pathologies.

Authors:  Philip Maier; Jens Funk
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-03-08       Impact factor: 3.117

10.  Resource use and costs associated with diabetic macular edema in elderly persons.

Authors:  Alisa M Shea; Lesley H Curtis; Bradley G Hammill; Jonathan W Kowalski; Arliene Ravelo; Paul P Lee; Frank A Sloan; Kevin A Schulman
Journal:  Arch Ophthalmol       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.